Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer

Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer

Prostate adenocarcinoma (PRAD) is a major threat to male health worldwide with a high mortality rate. New therapeutic strategies for the treatment of this malignant disease are of tremendous significance. Much attention has been paid to the involvement of immune cells in the prevention and treatm...

Full description

Bibliographic Details
Main Authors: Yidan Sun, Xinyu Yang, Shiqi Ren, Zhichao Lu, Zongheng Liu, Fanming Kong, Ziheng Wang, Yang Yang
Format: Article
Language:English
Published: MRE Press 2023-11-01
Series:Journal of Men's Health
Subjects:
prostate cancer
tumor immune microenvironment
immune checkpoint inhibitor
immunotherapy
prognostic model
Online Access:https://oss.jomh.org/files/article/20231130-155/pdf/JOMH2023020601.pdf

Similar Items

Similar Items